John G Heider

Title: Innovations of John G. Heider

Introduction

John G. Heider is a notable inventor based in West Nyack, NY (US). He has made significant contributions to the field of pharmaceuticals, holding a total of three patents. His work focuses on the development of novel compounds that have potential therapeutic applications.

Latest Patents

His latest patents include innovative compounds such as N-Unsaturated fatty acid amides of tryptophan ester homologues and ethylenically unsaturated fatty acid amides of tryptophan derivatives. These compounds, such as alpha-[1-oxo-9-octadecenylamino]-1H-indole-3-propanoic acid, ethyl ester, are recognized for their utility as pharmaceutical agents. They can be synthesized by reacting a mixed anhydride of a long-chain unsaturated carboxylic acid with an appropriate tryptophan ester. Additionally, he has developed cyclopropanyl-bearing amides of tryptophan, which are also useful as pharmaceutical agents. These compounds, including N-[1-(benzyl)-2-(phenyl)ethyl]-cis-2-octyl-cyclopropanoctanamide, can be obtained by reacting a mixed anhydride of a cyclopropanyl-group-bearing long-chain carboxylic acid with an appropriate amino compound.

Career Highlights

John G. Heider is currently associated with Sandoz GmbH, where he continues to innovate in the pharmaceutical sector. His work has contributed to advancements in drug development and therapeutic applications.

Collaborations

He collaborates with Faizulla G. Kathawala, enhancing the research and development efforts within their field.

Conclusion

John G. Heider's contributions to pharmaceutical innovations through his patents demonstrate his commitment to advancing medical science. His work continues to have a significant impact on the development of new therapeutic agents.